Minnesota Senate Bill SF3716

Minnesota 2025-2026 Regular Session

• Introduced: 2/19/26
• Refer: 2/19/26
• Refer: 3/9/26

Caption

Health plans to cover cervical cancer screening tests and subsequent diagnostic services requirement and appropriation

Impact

The implementation of this bill is expected to significantly alter the landscape of healthcare coverage in Minnesota, especially regarding preventive health services for women. By ensuring that health plans cover these essential services, the bill aligns with broader public health objectives to increase screening rates and reduce the incidence of cervical cancer. Additionally, the bill mandates reimbursement mechanisms for health plan companies, which could influence their policies and operational frameworks, potentially creating a ripple effect on how insurance providers approach coverage for similar preventive care services.

Summary

SF3716 requires health plans in Minnesota to cover pap tests and any necessary subsequent diagnostic services without imposing cost-sharing requirements on the patient. The bill is aimed at improving access to essential preventive care for women by ensuring that financial barriers do not impede their ability to receive necessary gynecological screenings and follow-up diagnostics. This mandate seeks to enhance early detection of cervical cancer and related health issues, thus aiming to improve health outcomes among women in the state.

Contention

While SF3716 is intended to broaden access to critical health services, there are points of contention surrounding its implementation, including concerns about the financial implications for insurance companies and the state. Critics may argue that the bill places undue financial burdens on health plan providers who must absorb these costs without the option to pass them along to consumers. Additionally, debates may arise over the appropriateness of state mandates in private health coverage, with some advocating for a more market-driven approach to such policies.